Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force

Author:

Whittle Sarah B.1ORCID,Offer Katharine2ORCID,Roberts Ryan D.3,LeBlanc Amy4,London Cheryl5,Majzner Robbie G.6,Huang Alex Y.7,Houghton Peter8,Alejandro Sweet Cordero E.9,Grohar Patrick J.10,Isakoff Michael11,Bishop Michael W.12ORCID,Stewart Elizabeth12,Slotkin Emily K.13,Greengard Emily14,Borinstein Scott C.15ORCID,Navid Fariba16,Gorlick Richard17,Janeway Katherine A.18ORCID,Reed Damon R.1920ORCID,Hingorani Pooja17

Affiliation:

1. Texas Children's Cancer and Hematology Centers, Department of Pediatrics Baylor College of Medicine Houston Texas USA

2. Joseph M. Sanzari Children's Hospital Hackensack Meridian Health Hackensack New Jersey USA

3. Center for Childhood Cancer and Blood Disease Nationwide Children's Hospital Columbus Ohio USA

4. Comparative Oncology Program, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland USA

5. Cummings School of Veterinary Medicine Tufts University North Grafton Massachusetts USA

6. Department of Pediatrics Stanford University School of Medicine Palo Alto California USA

7. Case Western Reserve University School of Medicine and UH Rainbow Babies & Children's Hospital Cleveland Ohio USA

8. Greehy Children's Cancer Research Institute UT Health San Antonio San Antonio Texas USA

9. Benioff Children's Hospitals, Department of Pediatrics University of California San Francisco San Francisco California USA

10. Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

11. Center for Cancer and Blood Disorders Connecticut Children's Medical Center Hartford Connecticut USA

12. Department of Oncology St. Jude Children's Research Hospital Memphis Tennessee USA

13. Memorial Sloan Kettering Cancer Center New York New York USA

14. University of Minnesota Masonic Cancer Center Minneapolis Minnesota USA

15. Department of Pediatrics, Division of Pediatric Hematology Oncology Vanderbilt University Medical Center Nashville Tennessee USA

16. Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles University of Southern California Los Angeles California USA

17. Division of Pediatrics University of Texas MD Anderson Cancer Center Houston Texas USA

18. Department of Pediatric Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

19. Johns Hopkins All Children's Hospital St. Petersburg Florida USA

20. Moffitt Cancer Center Department of Individualized Cancer Management Tampa Florida USA

Funder

National Cancer Institute

St. Baldrick's Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3